Translucence Biosystems presents at the 7th Annual BRAIN Initiative Investigators Meeting

Damian Wheeler
June 15, 2021

Translucence Biosystems is honored to present at the 7th Annual BRAIN Initiative Investigators Meeting. Our presentation is entitled, "Measurement of Npas 4 and cFos for Brain-Wide Snapshots of Neuronal Activity". Access our presentation poster here.

Recent advances in optical clearing and light sheet imaging have opened an exciting new avenue for brain-wide, cellular resolution immunostaining at the forefront of a dimensional shift from 2D to 3D histology. Translucence Biosystems has developed the Mesoscale Imaging SystemTM which adapts the ZEISS Lightsheet Z.1 microscope, designed for imaging small live organisms, to image large intact tissues with unprecedented speed and resolution. Traditional immediate-early gene (IEG) products such as cFos are turned on by neuronal activity, but also by cAMP and various paracrine factors. Npas4 is unique among IEGs in that it is neuron-specific and exquisitely tuned to Ca2+ signaling.

We developed a recombinant rabbit monoclonal anti-NPAS4 antibody (Activity Signaling: that we are using to generate cellular-resolution brain-wide signatures of neuronal activity. Using a modified version of iDISCO, we are optically clearing and immunostaining intact brains to mark neurons expressing cFos and Npas4. Our machine-learning enabled software, 3TK, surveys 3D- rendered whole brains to identify individual stained cells, map them to the Allen Brain Reference Atlas and quantify their expression across 100’s regions.

Our data show that cFos is expressed in a large number of neurons in control brains, whereas Npas4 expression at baseline is much lower. Behavioral manipulations that increase neuronal activity drive the expression of both cFos and Npas4, but the lower baseline expression of Npas4 provides for a higher fidelity readout of neuronal activity.

Ask your question

Send us your questions and we will get back to you as soon as possible

Thank you! Your submission has been received!
Something went wrong while submitting the form.
Please, contact via us direct email info@translucencebio.comand

Recent news

January 31, 2023

Translucence Biosystems Participates in Keystone Meeting on Drug Delivery to the Brain

Our team has been working with Lundbeck to monitor therapeutic antibody biodistribution in the brain using tissue clearing and light sheet imaging. Our CEO, Damian Wheeler, Ph.D. presented our findings in our poster titled the "Brain-Wide Cellular-Resolution Measurement of Antibody Therapeutics."
Translucence Biosystems
November 13, 2022

Translucence Biosystems Presents at SfN 2022

The Translucence team, including Nate Guanzon, Chase Redd, and CEO Damian Wheeler presented our BRAIN Initiative-funded work on whole-brain quantification neuronal activity with Npas4 and cFos at SfN 2022.
Translucence Biosystems
May 4, 2022

Co-Founder, Sunil Gandhi Ph.D., presents at the 8th Annual Bench to Bedside Symposium

Co-Founder, Sunil Gandhi Ph.D., presents at the 8th Annual Bench to Bedside Symposium hosted by the Gavin Herbert Eye Institute at the University of California, Irvine School of Medicine.
Angela Prvulovic